Profiel
Adam Shilling worked as an Executive Director of Global Regulatory Affairs at Incyte Corp.
He then worked as a Vice President of Early Development at Prelude Therapeutics, Inc. from 2019 to 2022.
Mr. Shilling received an undergraduate degree from Long Island University and a doctorate degree from Oregon State University.
Eerdere bekende functies van Adam Shilling
| Bedrijven | Functie | Einde |
|---|---|---|
| PRELUDE THERAPEUTICS INCORPORATED | General Counsel | 01-04-2022 |
| INCYTE CORPORATION | General Counsel | - |
Opleiding van Adam Shilling
| Long Island University | Undergraduate Degree |
| Oregon State University | Doctorate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
14
Eerstegraads connecties
4
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 2 |
|---|---|
| INCYTE CORPORATION | Health Technology |
| PRELUDE THERAPEUTICS INCORPORATED | Health Technology |
